UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of lymph nodes in squamous cell carcinoma of the cervix: touch imprint cytology versus frozen section histology

International journal of gynecological cancer, 1999-07, Vol.9 (4), p.337-341

1999

Volltextzugriff (PDF)

Aktuelle Studien zur Therapie des Zervixkarzinoms in den USA

Onkologie (Heidelberg, Germany), 2001-08, Vol.7 (8), p.889-892

2001

Volltextzugriff (PDF)

Die Kolposuspension mit BSC direct – Minimal invasiv, maximal effektiv

Geburtshilfe und Frauenheilkunde, 2014, Vol.74 (S 01)

2014

Volltextzugriff (PDF)

ADENOVIRAL MEDIATED THYMIDINE KINASE GENE THERAPY FOR OVARIAN CANCER USING AN ESTROGENINDUCIBLE PROMOTER: A STEP TOWARDS TUMOR-SPECIFIC GENE THERAPY

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.12-12

2003

Volltextzugriff (PDF)

Increased progression-free and overall survival in patients with breast cancer with menopausal symptoms or arthralgia/myalgia during adjuvant treatment with exemestane or tamoxifen: Results of the German TEAM trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.523-523

2011

Volltextzugriff (PDF)

COMBINED GENE- AND CHEMOTHERAPY FOR TREATMENT OF OVARIAN CANCER: IN-VITRO ANALYSIS OF COMBINED TREATMENT WITH A REPLICATION-DEFICIENT ADENOVIRAL VECTOR AND TOPOTECAN

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.12-12

2003

Volltextzugriff (PDF)

Die Kolposuspension mit BSC transischiorektal – 5-Jahres Langzeitergebnisse

Geburtshilfe und Frauenheilkunde, 2014, Vol.74 (S 01)

2014

Volltextzugriff (PDF)

Abstract P1-06-04: Simplified histological grading of breast carcinoma – potential for improved concordance and consistency in breast cancer grading?

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-06-04

2018

Volltextzugriff (PDF)

Abstract P1-06-02: Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-06-02

2018

Volltextzugriff (PDF)

Abstract PD4-11: Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD4-11-PD4-11

2018

Volltextzugriff (PDF)

Der besondere Fall: Vaginaler Fremdkörper (Zange) als Zufallsbefund anläßlich der Primäroperation eines Mammakarzinomes

Geburtshilfe und Frauenheilkunde, 1995-04, Vol.55 (4), p.233-234

1995

Volltextzugriff (PDF)

Bone effects of exemestane versus tamoxifen within the TEAM Trial: Results of a prospective randomized bone substudy

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.572-572

2008

Volltextzugriff (PDF)

Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer

International journal of gynecological cancer, 2002-01, Vol.12 (1), p.66-73

2002

Volltextzugriff (PDF)

Abstract P2-08-29: Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-08-29

2016

Volltextzugriff (PDF)

P2-17-02: Increased Progression Free and Overall Survival in Breast Cancer Patients with Menopausal Symptoms or Arthralgia/Myalgia during Adjuvant Treatment with Exemestane or Tamoxifen – Results of the German TEAM Trial

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-17-02

2011

Volltextzugriff (PDF)

MECHANISM OF ACTION AND DURATION OF TRANSLATION OF THE THYMIDINE KINASE GENE IN ADENOVIRUS-MEDIATED GENE THERAPY OF OVARIAN CANCER

Anticancer research, 2008-10, Vol.28 (5C)

2008

Volltextzugriff (PDF)

Endometrial effects of exemestane compared to tamoxifen within the TEAM trial: Results of a prospective randomized study

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.572-572

2007

Volltextzugriff (PDF)

Abstract S1-5: PIK3CA mutations are linked to PgR expression: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) pathology study

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.S1-S1-5

2012

Volltextzugriff (PDF)

Comparison of Long-term Survival of Cytomegalovirus Promoter versus Rous Sarcoma Virus Promoter-Driven Thymidine Kinase Gene Therapy in Nude Mice Bearing Human Ovarian Cancer

Hybridoma, 1999-02, Vol.18 (1), p.93-97

1999

Volltextzugriff (PDF)

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

Annals of oncology, 2004-03, Vol.15 (3), p.440-449

2004

Volltextzugriff (PDF)

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

Cancer gene therapy, 2002-05, Vol.9 (5), p.478-481

2002

Volltextzugriff (PDF)

Aktuelle Studien zur Therapie des Zervix- karzinoms in den USA

Onkologie (Heidelberg, Germany), 1998-02, Vol.4 (2), p.180-184

1998

Volltextzugriff (PDF)

Functional characterization of somatic point mutations of the human estrogen receptor ± (hER±) in adenomyosis uteri

Molecular human reproduction, 2004-12, Vol.10 (12), p.853

2004

Volltextzugriff (PDF)

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: Expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5

Journal of the Society for Gynecologic Investigation, 2002-06, Vol.9 (3), p.174-180

2002

Volltextzugriff (PDF)

Mutationen des p53 Tumorsuppressor-Gens beim Mammakarzinom und Suppression des neoplastischen Phänotyps durch Wildtyp p53

Archives of gynecology and obstetrics, 1993-12, Vol.254 (1-4), p.834-836

1993

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(33)
Deutsch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of lymph nodes in squamous cell carcinoma of the cervix: touch imprint cytology versus frozen section histology

Aktuelle Studien zur Therapie des Zervixkarzinoms in den USA

Die Kolposuspension mit BSC direct – Minimal invasiv, maximal effektiv

ADENOVIRAL MEDIATED THYMIDINE KINASE GENE THERAPY FOR OVARIAN CANCER USING AN ESTROGENINDUCIBLE PROMOTER: A STEP TOWARDS TUMOR-SPECIFIC GENE THERAPY

Increased progression-free and overall survival in patients with breast cancer with menopausal symptoms or arthralgia/myalgia during adjuvant treatment with exemestane or tamoxifen: Results of the German TEAM trial

COMBINED GENE- AND CHEMOTHERAPY FOR TREATMENT OF OVARIAN CANCER: IN-VITRO ANALYSIS OF COMBINED TREATMENT WITH A REPLICATION-DEFICIENT ADENOVIRAL VECTOR AND TOPOTECAN

Die Kolposuspension mit BSC transischiorektal – 5-Jahres Langzeitergebnisse

Abstract P1-06-04: Simplified histological grading of breast carcinoma – potential for improved concordance and consistency in breast cancer grading?

Abstract P1-06-02: Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?

Abstract PD4-11: Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Der besondere Fall: Vaginaler Fremdkörper (Zange) als Zufallsbefund anläßlich der Primäroperation eines Mammakarzinomes

Bone effects of exemestane versus tamoxifen within the TEAM Trial: Results of a prospective randomized bone substudy

Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer

Abstract P2-08-29: Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial

P2-17-02: Increased Progression Free and Overall Survival in Breast Cancer Patients with Menopausal Symptoms or Arthralgia/Myalgia during Adjuvant Treatment with Exemestane or Tamoxifen – Results of the German TEAM Trial

MECHANISM OF ACTION AND DURATION OF TRANSLATION OF THE THYMIDINE KINASE GENE IN ADENOVIRUS-MEDIATED GENE THERAPY OF OVARIAN CANCER

Endometrial effects of exemestane compared to tamoxifen within the TEAM trial: Results of a prospective randomized study

Abstract S1-5: PIK3CA mutations are linked to PgR expression: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) pathology study

Comparison of Long-term Survival of Cytomegalovirus Promoter versus Rous Sarcoma Virus Promoter-Driven Thymidine Kinase Gene Therapy in Nude Mice Bearing Human Ovarian Cancer

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

Aktuelle Studien zur Therapie des Zervix- karzinoms in den USA

Functional characterization of somatic point mutations of the human estrogen receptor ± (hER±) in adenomyosis uteri

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: Expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5

Mutationen des p53 Tumorsuppressor-Gens beim Mammakarzinom und Suppression des neoplastischen Phänotyps durch Wildtyp p53

Aktive Filter

Suchergebnisse filtern